Open Heart (Nov 2023)

Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation

  • Gregory Y H Lip,
  • Chris P Gale,
  • Jianhua Wu,
  • Ramesh Nadarajah,
  • Catherine Reynolds,
  • David Hogg,
  • Ali Wahab,
  • John Keene,
  • Campbel Cowan,
  • Keerthenan Raveendra,
  • Deborah Askham,
  • Richard Dawson,
  • Sagar Shanghavi

DOI
https://doi.org/10.1136/openhrt-2023-002447
Journal volume & issue
Vol. 10, no. 2

Abstract

Read online

Introduction Atrial fibrillation (AF) is associated with a fivefold increased risk of stroke. Oral anticoagulation reduces the risk of stroke, but AF is elusive. A machine learning algorithm (Future Innovations in Novel Detection of Atrial Fibrillation (FIND-AF)) developed to predict incident AF within 6 months using data in primary care electronic health records (EHRs) could be used to guide AF screening. The objectives of the FIND-AF pilot study are to determine yields of AF during ECG monitoring across AF risk estimates and establish rates of recruitment and protocol adherence in a remote AF screening pathway.Methods and analysis The FIND-AF Pilot is an interventional, non-randomised, single-arm, open-label study that will recruit 1955 participants aged 30 years or older, without a history of AF and eligible for oral anticoagulation, identified as higher risk and lower risk by the FIND-AF risk score from their primary care EHRs, to a period of remote ECG monitoring with a Zenicor-ECG device. The primary outcome is AF diagnosis during ECG monitoring, and secondary outcomes include recruitment rates, withdrawal rates, adherence to ECG monitoring and prescription of oral anticoagulation to participants diagnosed with AF during ECG monitoring.Ethics and dissemination The study has ethical approval (the North West—Greater Manchester South Research Ethics Committee reference 23/NW/0180). Findings will be announced at relevant conferences and published in peer-reviewed journals in line with the Funder’s open access policy.Trial registration number NCT05898165.